GC Pharma Reports Full Year 2017 Results

YONGIN, South Korea, Feb. 4, 2018 /CNW/ — GC Pharma (formerly known as Green Cross Corporation) (KRX: 006280), a South Korean biopharmaceutical company, today announced unaudited results for the year ended 31 December 2017.

Key Figures

Full Year 2017

Growth(1)

Total revenues

KRW 1,287.9 billion

+7.5%

Operating income

KRW 90.3 billion

15.1%

K-IFRS net income

KRW 56.7 billion

(13%)

(1) Results and percentages to the full financial year 2016